Clinical Research Directory

Retrospective Observational Study on Infective Complications and Outcome of Patients With ALL Treated With INO

Sponsor: Gruppo Italiano Malattie EMatologiche dell'Adulto

Summary

The goal of this observational study is to learn about infectious complications in patients affected by B-cell acute lymphoblastic leukemia treated with inotuzumab-ozogamicin (INO). The main question it aims to answer is: • incidence of infectious complications (bacterial, fungal, viral) in patients receiving inotuzumab ozogamicin up to 60 days after the end of treatment

Official title: Multicenter Retrospective Observational Study Analyzing Infective Complications and the Clinical Outcome of Patients With Acute Lymphoblastic Leukemia Treated With Inotuzumab Ozogamicin (INO-FIRST)

Key Details

Conditions

Locations (1)